College-age students who drink heavily may increase their risk for future heart disease, researchers reported at the American Heart Association’s 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology.
A report of data from the National Cancer Institute?s Surveillance Epidemiology and End Results (SEER) database published in the New England Journal of Medicine, suggests that a decline in breast cancer incidence may be caused by a drop in hormone therapy use during the same time period.
Researchers at Fox Chase Cancer Center have identified an important gene involved in the spread of breast cancer that has developed resistance to long-term estrogen deprivation. The discovery was reported today in an oral presentation during the 97th Annual Meeting of the American Association for Cancer Research in Los Angeles.
Following a report of the analysis of data from the SEER registries of the NCI, showing that the incidence of breast cancer fell by 6.7 percent in 2003 in the US, and the suggestion that the data might be linked to the decrease in the use of postmenopausal hormones, the IMS advises caution in linking these two trends and recommends that hormone therapy be prescribed whenever indicated.
Among men who have received similar treatments for prostate cancer, those with less education ? particularly those who did not graduate from high school ? experience a significant drop in their quality of life after treatment compared with men who have more education, according to a study led by researchers at the San Francisco VA Medical Center (SFVAMC).
Measuring a man?s daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.
A new study published in the Journal of the American Medical Association found no increased risk of heart attack for women in their 50s who were taking HRT.
A senior UK oncologist Chris Hamilton admitted that thousands of men with prostate cancer are being given unnecessary and potentially harmful drug treatment to clear hospital waiting lists in UK.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), provides comment on a re-analysis of pooled data from both hormone therapy arms of the Women?s Health Initiative (WHI) Study published in the Journal of the American Medical Association.
Women who initiate hormone therapy closer to menopause tend to have a reduced risk of coronary heart disease compared to women who begin treatment further from menopause, but researchers did not find this reduced risk was statistically significant, according to a study in the April 4 issue of JAMA.